The first study.

The first study, be published in the February issue of Gastroenterology that a new multi-marker stool DNA test at detecting at detecting precancerous polyps and early stage colon cancer. This is the first large-scale, blinded study of the new tests to measure the effectiveness.

This is the of colon cancer, New Test Offers Greater AccuracyThe results of two studies suggest that a new investigative cancer screening test in a collaboration between Mayo Clinic and Exact Sciences Inc. Of Madison, Wisconsin developed highly accurate and is more sensitive than other invasive tests. At detecting precancerous tumors and early cancer These results have important implications for clinicians and tens of thousands of Americans. Early detection is a key driver of better outcomes for colorectal cancer – a disease that affects 1 in every 17 persons and is the second leading cause of U.S. Cancer deaths.Metabolic syndrome is a cluster of cardio disease and diabetes risk factors including excessive waist measurement, high blood pressure, elevated triglycerides, low range from high-density lipoprotein and high blood sugar levels. The presence of three or more of said factors increases the risk of of developing diabetes and cardiovascular disease. – ‘The study suggests Fr women to develop cardiac risk factors sooner than Caucasus its counterparts and that is Hispanic could be an independent risk factor to heart disease in women, ‘Teeters told.

Related Posts

Other Posts From Category "hepatology":